Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.810
+0.010 (0.36%)
At close: Jun 8, 2026, 4:00 PM EDT
2.820
+0.010 (0.36%)
After-hours: Jun 8, 2026, 7:41 PM EDT
Evotec SE Employees
Evotec SE had 4,526 employees as of March 31, 2026. The number of employees decreased by 240 or -5.04% compared to the same quarter last year.
Employees
4,526
Change
-240
Growth
-5.04%
Revenue / Employee
$189,800
Profits / Employee
-$49,390
Market Cap
1.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 4,526 | -240 | -5.04% |
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Xeris Biopharma Holdings | 435 |
| Collegium Pharmaceutical | 423 |
| Harrow | 373 |
EVO News
- 6 days ago - Evotec SE: Evotec Appoints Rui Wang as Head of Global In Silico and AI - Finanz Nachrichten
- 6 days ago - Evotec Appoints Rui Wang as Head of Global In Silico and AI - Accesswire
- 10 days ago - EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 17 days ago - EQS-DD: Evotec SE: Dr. Cord Dohrmann, sell - Wallstreet:Online
- 27 days ago - Evotec SE (EVO) Issues â¬116.1M Convertible Bonds to Support Project Horizon - GuruFocus
- 27 days ago - Evotec SE Successfully Placed €116.1 Million Convertible Bonds - Accesswire
- 27 days ago - EQS-Adhoc: Evotec SE launches approximately EUR 125 million convertible bond offering - Wallstreet:Online
- 4 weeks ago - EQS-DD: Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online